CMS: 2009 Average Sales Price of Drugs (What the drugs REALLY cost)

Now you can find out the ACTUAL price of I.V. medications, including those given to people on dialysis, such as Epoetin alfa (less than $10 per 1,000 units).

2009 ASP Drug Pricing Files

Average Sale Price (ASP) Drug Pricing Files January 2009 Update
The files below contain the payment amounts that will be used to pay for Part B covered drugs for the first quarter of 2009. Comparing the first quarter 2009 payment amounts with the previous quarter reveals that for the most part average drug prices in the market remain stable. Overall, average payment amounts across the top physician administered drugs and average payment amounts across all drugs increased one percent.

For most of the higher volume drugs (32 out of the top 50), the payment amounts changed 2 percent or less. Overall, the payment amounts for 39 of the top 50 drugs increased, while 1 remained the same. For the first quarter of 2009, the Medicare payment amount is increasing up to 2.7 percent for IVIG. In general, among the top drugs with a decrease, there are a number of competitive market factors at work – multiple manufacturers, alternative therapies, new products, recent generic entrants, or market shifts to lower priced products.

CMS remains interested in ensuring continued beneficiary access to Part B covered drugs. We will continue to monitor trends in pricing, as reflected by the published ASP payment rates, as well as utilization within the Medicare community.

Where applicable, the payment amounts in the quarterly ASP files are 106 percent of the Average Sales Price (ASP) calculated from data submitted by drug manufacturers. The quarter to quarter price changes are generally the result of updated data from the manufacturers of these drugs.

http://www.cms.hhs.gov/McrPartBDrugAvgSalesPrice/01a1_2009aspfiles.asp#TopOfPage
Download from above web site:
January 2009 ASP Pricing File [ZIP, 41KB]